-
2023-505604-32-00
5
2024-01-24
Non small cell lung cancer (NSCLC)
-
2023-503290-38-00
4
2023-09-05
Bronchiectasis
-
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
-
2023-509810-13-00
4
2023-05-13
Acute Lymphoblastic Leukemia (ALL)
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2023-505539-11-00
10
2023-04-06
Pulmonary Arterial Hypertension
-
2022-500391-62-00
9
2023-01-19
Subjects with relapsed/refractory peripheral T-cell lymphoma (R/R PTCL
-
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
-
2023-509138-21-00
5
2021-08-26
Pulmonary Arterial Hypertension (PAH)
-
2023-503465-33-00
5
2020-07-03
Cholestasis
-
2023-504694-20-00
9
2017-01-13
pediatric CD22-positive relapsed/refractory Acute Lymphoblastic Leukem
-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
-
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2025-522012-16-00
4
2026-03-13
Breast Cancer
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2024-511362-37-00
5
2026-02-18
Non squamous non-small cell lung cancer (NSCLC)
-
2025-521849-25-00
4
2026-02-17
Chronic Graft-Versus-Host Disease
-
2023-509377-23-00
6
2026-02-13
Patients with currently remitted depressive disorders.
-
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer
-
2024-518777-34-00
5
2026-02-11
B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
-
2024-515765-34-00
5
2026-02-04
English
First-line extensive-stage small-cell lung cancer (ES-SCLC)